P. Ghadjar

Publications170
h-index30
Citations2,825
Highly Influential Citations99
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • P. Wust
  • 412 Publications, 15,981 Citations
  • V. Budach
  • 341 Publications, 11,829 Citations
  • A. Briganti
  • 1,920 Publications, 27,200 Citations
  • J. Crezee
  • 156 Publications, 2,799 Citations
  • Publications
  • Influence
Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate…
For series referred to as ‘EBRT’, Reference #56 used RT doses < 72 Gy and should not be eligible for the present analysis. The sample size of Reference #35 should be reconsidered, as some of the… Expand
  • 146
  • 12
Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer.
PURPOSE To determine the potential association between genitourinary (GU) toxicity and planning dose-volume parameters for GU pelvic structures after high-dose intensity modulated radiation therapy… Expand
  • 91
  • 8
Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer.
PURPOSE The liver is the primary organ of metastasis in colorectal cancer (CRC). Chemokine receptor CCR6 is expressed on a subset of T cells and is associated with their migration into the liver.… Expand
  • 122
  • 7
The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network.
PURPOSE To evaluate the role of postoperative radiotherapy (RT) in Merkel cell carcinoma (MCC). METHODS AND MATERIALS A retrospective multicenter study was performed in 180 patients with MCC… Expand
  • 60
  • 4
Comparative risk‐adjusted mortality outcomes after primary surgery, radiotherapy, or androgen‐deprivation therapy for localized prostate cancer
  • 63
  • 4
Early-stage primary bone lymphoma: a retrospective, multicenter Rare Cancer Network (RCN) Study.
PURPOSE Primary bone lymphoma (PBL) represents less than 1% of all malignant lymphomas. In this study, we assessed the disease profile, outcome, and prognostic factors in patients with Stages I and… Expand
  • 45
  • 4
Comparison of high‐dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate‐risk prostate cancer
To compare tumour control and toxicity outcomes with the use of high‐dose intensity‐modulated radiation therapy (IMRT) alone or brachytherapy combined with IMRT (combo‐RT) for patients with… Expand
  • 100
  • 3
  • PDF
The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer
Chemokines are a superfamily of small chemotactic cytokines, which interact with their G‐protein‐coupled receptors. These interactions regulate multiple physiological functions, particularly tissue… Expand
  • 122
  • 3
Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma.
PURPOSE We performed a histopathologic analysis to assess the extent of the extracapsular extension (ECE) beyond the capsule of metastatic lymph nodes (LN) in head and neck cancer to determine… Expand
  • 41
  • 3
Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis.
The stromal-derived factor 1alpha (CXCL12)/chemokine receptor CXCR4 system plays an important role in the metastatic process of a variety of cancers, with CXCR4 frequently expressed by tumor cells… Expand
  • 66
  • 3